Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

US Department of Veterans Affairs (VA)

Status and phase: Completed; Phase 2

Conditions: Prostate Cancer

Treatments: Drug: Chemotherapy

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT00108290

CLIN-003-02F

Details and patient eligibility

About

In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.

Sex: Male

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• High risk prostate cancer without evidence of bone metastasis.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)